|
CURRICULUM VITAE R. STEVEN PADILLA, M.D., EXECUTIVE MBAChairman, UNM SOM
Department of Dermatology OFFICE ADDRESS: University of
New Mexico School of Medicine PLACE OF BIRTH: Santa Fe, NewMexico, USA EDUCATION AND TRAINING: College Education: New Mexico State University, Las Cruces, New Mexico. August 1967-June 1971, B.S. Masters: MBA, University of New Mexico, Anderson School of Management. June 1991-August 1993 Medical Education: University of New Mexico, School of Medicine, Albuquerque,New Mexico, August 1971-May 1975, M.D. Internship: Maricopa County
General Hospital, Phoenix, Arizona June 1975-June1976; Categorical Medicine
Dermatology Training: Resident in Dermatology, University of New Mexico, School of Medicine, Albuquerque, New Mexico, July 1977-July 1980Chief Resident in Dermatology, June 1979-July 1980 Fellowship in Dermatopathology, University of Minnesota, Medical School, Minneapolis, Minnesota, July 1980-July 1981 Fellowship in Dermatologic Surgery and Oncology, The Cleveland Clinic, Cleveland, Ohio, July 1981-July 1982
ACADEMIC
APPOINTMENTS: Chair, Department of Dermatology, November 1, 1996-present Associate Dean for Practice Management, 2000-present President and CEO, University Physicians Associates, 2000-present Chief, Dermatologic Surgery and Oncology (Cancer Center), University of New Mexico School of Medicine, 1982-present Professor of Dermatology, 1992-present Associate Professor of Dermatology, 1986-1992 Associate Professor of Pathology, 1991-present Assistant Professor of Pathology, 1991-1992 Assistant Professor of Dermatology/Medicine, 1982-1986 BOARD
CERTIFICATION: American Board of Dermatology, November 3, 1980 American Board of Dermatology & American Board of Pathology Dermatopathology, November 3, 1981 American Board of Mohs Micrographic Surgery and Cutaneous Oncology, June 29, 1991 Diplomat, National Board of Medical Examiners, 1976
LICENSURE: Arizona 9472 (Inactive) Issued: 1976 Minnesota 0257167 (Inactive) Issued: 1980 New Mexico 78-00234 Issued: 1978 PRESENT APPOINTMENTS: Clinical Staff, University of New Mexico Hospital/BCMC Consulting Staff, Presbyterian Hospital, Albuquerque, New Mexico
PRESENT
APPOINTMENTS (CONTINUED): Dermatology Consultant, Student Health Center, UNM Consulting Staff, Veterans Administration Medical Center, Albuquerque, New Mexico Staff Member, University of New Mexico, Cancer Center Medical Director, UNM Medical Arts Clinics, 2000-present FORMER APPOINTMENTS: Medical Director, UNM Pinetree Clinics, 1997-2000 Staff Physician, Maricopa County General Hospital, Phoenix, Arizona, July 1976-July 1977 Instructor in Dermatology, University of Minnesota, Medical School, Minneapolis, Minnesota, July 1980-July1981 Acting Chairman, Department of Dermatology, University of New Mexico, School of Medicine, Albuquerque, New Mexico, May 1984-October 1984 Interim Chairman, Department of Dermatology, University of New Mexico, School of Medicine, Albuquerque, New Mexico October 1993-October 1994 ACADEMIC APPOINTMENTS:
University
Dermatology Residency Selection Committee, 1982-present Human Research Review Committee, University of New Mexico, School of Medicine, 1983-1988 Tissue, Transfusion and Autopsy Committee, University of New Mexico Hospital, 1983-1987 Oncology Committee, University of New Mexico Hospital/BCMC 1983-1991 Dean’s Advisory Committee on Latin America, 1989-1990 University Physician’s Associates, Board Member 1990-present Executive Committee Member, 1991-1994 Formula Revision Task Force, 1995 AD HOC Committee – Promotions (to Associate Professor), 1992-1995 Medical Staff Executive Committee, 1994 Center for Population Health – Advisory Group, 1994-1996 Search Committee for UNM Medical Center Budget Director, 1994 Organizer of UNM Inter-Campus Retreat on Underrepresented Populations, October 1994 Search Committee for Vice President for Student Affairs, 1995 Governance and Administration Committee, Liaison Committee to prepare for Medical Education Accreditation Site Visit, 1995 Telemedicine Committee, UNM School of Medicine, 1993-1994 UNM Professional Mentorship Program Participant, Program by UNM President Richard Peck, 1994-1995 University of New Mexico, Office of Ethnic and Cultural Affairs (OCEP), Executive Committee Chair, 1994-1995 Medical Records Committee Member, 1996-1998 Committee of Chairman, 1996-present Search Committee for Research Faculty on Metastatic Melanoma, Department of Molecular and Cell Biology, 1998 Chair, Search Committee, OB/GYN Chair Search, 1997 Faculty Positions Review Committee, ad hoc, 1998 Dermatology Program Director, UNM/SOM, 1997-present “New Units” Task Force – UNM Provost’s Office, 1999 Compliance Committee, 1999-present Search Committee for Cancer Center COO-1999 Contract Committee, 2000-present Clinical Leaders Group, 2000-present Search Committee Chair of Internal Medicine, 2001 Governance and Administration Committee – LCME, 2001-2003 School of Medicine Facility and Capital Equipment Task Force, 2002 Search Committee, UPA CFO, 2002 Task Force on Department Reviews, 2003 Search Committee, HSC Compliance Officer, 2003
National/Scientific Organizations American Academy of Dermatology, Fellow, 1982-present Committee on Regulatory Affairs, 1982-1988 Health Care Finance Committee, 2003-2007 American College of Mohs Micrographic Surgery and Cutaneous Oncology Exhibits Committee, 1986 Dermatopathology Committee, 1986-present Fellowship Training Program Committee, 1989-1994 Tumor Registry Director, 1989-1994 Board of Directors, 1991-1994 Task Force on Laboratory Proficiency – Co-Chair, 1991-present Program Director ACMMSCO, May 1994 Meeting Scientific Program Committee, 1994
Task Force on
Information Systems and Tumor Registry Task Force on Membership, 1994-1995 Task Force on Journal Contract Negotiation, 1994-1995 Task Force on Teaching Library Development,1998-2000 American Society of Dermatopathology Committee on Job Placement, 1986-1988 Membership Committee, 1991-1994, Chair, 1994 Board of Directors, 1993 American Society for Dermatologic Surgery Board of Directors, 1992-1995 Membership Committee, 1992-1995, Chair 1995 Task Force on Special Certification in Dermatologic Surgery, 1989-1992 Ethics Committee, 1993-present Membership Review Committee, 1992-1995 Chair of Committee, 1995 Task Force – Strategic Implementation Plan, 1994 Strategic Planning Group Leader, 1993 Residency Training Committee, 1997-2000 American Board of Mohs Micrographic Surgery and Cutaneous Oncology, Board Member, 1991-present Association of Academic Dermatologic Surgeons, 1989-present Association of Professors of Dermatology, 2000-present American Dermatological Association, Member, 2000-present First 5-Year Committee National Hispanic Medical Association, Member of Cultural Competence Assessment Project, Advisory Committee, April 6, 2002,Washington,D.C. Greater Albuquerque Medical Association
(GAMA), Member New Mexico Medical Society,
Member Society for Investigative Dermatology International Society of Dermatologic Surgery New Mexico Dermatological Society Vice-President, March 1987-1988 President, March 1988-1989 New Mexico Dermatology Foundation, Inc., Director, 1979-1980 New Mexico Health Coalition (Skin Cancer Project) Medical Advisory Committee, Southwestern Dermatological Society PROJECTS: Hemispheric Initiatives – reorganization, published and distributed (institutionalized) December 1995 University of Michoacan, Morelia Mexico Liaison, February 1995 University of New Mexico Kids Tour Program – obtained financial support from local businesses, 1995 EDITORIAL FUNCTIONS: Journal of Dermatologic Surgery and Oncology Contributing Editor, 1987-1994 Special Contributing Editor, 1994-1997 AD HOC Reviewer: J Am Acad Derm, Archives of Derm, J of Investigative Derm, Am J of Dermpath, J of Derm Surg Onc, Pediatric Dermatology Textbook proposal reviewer for Lippincott, Williams & Wilkins SOCIETIES: Tri Beta Honorary, New Mexico State University, Las Cruces, New Mexico 1970-1971 RESEARCH ACTIVITIES: Principal Investigator: Syntex Pharmaceuticals “Pilot Parallel Comparison Trial of RS-10025-002 Gel 2.5% and its Vehicle for Treating Comedonal Acne Vulgaris,” 1990 Co-PI/Director, MARC National Research Service Award, National Institute of Health, $176,7520, 1994 Advisory Committees, MARC, 1995 Co-PI/Director, Minority Biomedical Research Support (MBRS), National Institute of Health, $120,000, 1994 Advisory Committee, MARC, 1995-present Co-PI/Director, Hispanic Center of Excellence (HCOE) Model Development, Department of Health and Human Services, $1,200,000, 1994-1996 and Human Services, Bureau of Health Professions, Rockville, Maryland, 1996 Principle Investigator, Center of Excellence: Hispanic and Native American, Department of Health and Human Services, $1,580,000, 1998-2001 Grant Reviewer for Centers of Excellence, Department of Health and Human Services, Rockville, Maryland, June 1999 and March 2000 Principal Investigator/Director, Minority Faculty Fellowships, Health and Human Services, Division of Disadvantaged Assistance, Bureau of Health Professions $94,132, July 1999 – June 2002 Co-Investigator – NCI R21/R33 Phased Technology Award. Molecular Staging of Human Squamous Cell Skin Cancer, $147,000, August 2000-July 2004 Principle Investigator, Border Health Consortium Contract, $10,000, August 2001 - August 2002 Principal Investigator: Fujisawa Healthcare, Inc. “Open Label Study to Evaluate the Safety of Topically Applied Tacrolimus Ointment for the Treatment of Atopic Dermatitis,” $30,000, 1999 - 2001 Peer Review Training Workshop, Division of Health Professions Diversity (COE) January 18-19, 2001, Rockville, Maryland. EDUCATION
ACTIVITIES: UNM Outpatient Teaching Workshop – September 19,1997 Tutor Training March 30-31, 1999 Tutor in Molecular Genetics – September 1999 Mentor, Medical Student Research Project, Ana Arizaga “Common Skin Conditions in Rural Dermatology Practice,” 2000 Human Research Review Committee Training Course, July 23, 2001 UNM Outpatient Teaching Workshop, May 16, 2002 Dermatology & Politics: Playing to Win. Lobby Course, October 10, 2002, Albuquerque, NM COMMUNITY ACTIVITIES: Sponsored Cookout for Children’s Hospital of New Mexico Organized local business leaders and conducted a barbecue Raised $1,000 – April 1994 Member, Advisory Working Group New Mexico State Legislative Interim Health Care Task Force – 1994 Participant in Mayor’s Gang Intervention Program – Tattoo removal for gang members, 1994-present Mayor’s Certificate of Appreciation for Outstanding Contributions to community youth, June 1995 New Mexico Medical Legal Panel Member, 1987-present New Mexico Hispanic Medical Association, Board of Directors, 1990-1994 Chair, Scholarship Committee Established and organized the committee. Collected $10,000 and established a scholarship foundation at UNM to fund a yearly scholarship for underrepresented population in Medicine. First scholarship given in 1994. Legislative Committee, 1995 Governors Conference Skin Cancer Screening, November 17, 1993 Albuquerque, New Mexico New Mexico Dermatological Society President, 1988 Secretary-Treasurer, 1993-present New Mexico Symphony Wine Auction Committee, 1996-present Spanish Colonial Arts Society Member and Volunteer, 1995-present Board of Directors, 1997-present Collection Committee, 1997-present Finance Committee, 1997-present Museum Study Committee, 1999 First Vice-President, 1999 and 2000 Building Committee, 1999 By-Laws Committee, 1999 Chair, Search Committee for Museum Director, 2000 ORIGINAL WORKS: 1. Padilla RS, Becker LE, Hoffman WH, Long G: Cutaneous and venous complications of pentazocine abuse. Arch Dermatol 115:975-977, 1977 2. Henry JC, Padilla RS, Becker LE, Bankhurst AD: Cell-mediated immunity in Darier’s disease. J Am Acad Dermatol 1:348-351, 1979 3. Padilla RS, Mason WV, Becker LE: Soaps in the management of xerosis. Cutis 23:363-366, 1979 4. Smith EB, Padilla RS, McCabe JM, Becker LE, 20% benzoyl peroxide lotion in acne. Cutis 24:90-92, 1980 5. Padilla RS, McCabe JM, Becker LE: Topical tetracycline hydrochloride vs. topical clindamycin phosphate in the treatment of acne: A comparative study. Int J Derm 20(6):445-448, 1981 6.
Padilla RS, Jaramillo M, Dao A, Chapman W: Cutaneous metastatic adenocarcinoma of
gallbladder origin. Arch Dermatol
118:515-517, 1982 7.
Padilla RS, Mukai K, Dahl M, Burgdorf WH, Rosai
J: Differential staining pattern of
lysozyme in palisading granulomas: An
immuno-peroxidase study. J Am Acad
Derm 8:634-638, 1983 8.
Padilla RS, Bailin PL, Howard WR, Dinner MI: Verrucous carcinoma of the skin and its
management by Mohs Surgery. Plast
Reconstr Surg 73:442-447, 1984 9. Padilla RS, Flynn K, Headington JT: Epithelioid sarcoma: Enzyme histochemical and electron microscopic evidence of histiocytic differentiation. Arch Dermatol 121:389-393, 1985 10. Walker NPH, Padilla RS: The carbon dioxide laser in dermatology. In the First British Conference on Lasers in Medicine and Surgery, Royal College of Surgeons of England, Lincoln’s Inn Fields, London, WC2, 1982 11. Padilla RS, Holguin T, Burgdorf WH, Dahl M: Serum lysozyme (muramidase) in patients with localized and generalized granuloma annulare. Arch Dermatol 121(5):624-625, 1985 12. Holguin H, Padilla RS, Ampuero F: Ovarian adenocarcinoma presenting with the sign of Leser-Trelat. Gynex Onc 25:128-132, 1986 13. Padilla RS, Mann E, Orkin M, Rosai J: Progressive capillary hemangioma (acquired tufted angioma). J Cut Pathol (abstr) 13(6) 456, 1986 14. Padilla RS, Doss LL, Hladik WB: Technetium antimony sulfur colloid scintiscan in selective lymph node dissection for malignant melanoma. J Dermatol Surg Onc 12(12):1280-1284, 1986 15. Padilla RS, Orkin M, Rosai J: Acquired “Tufted” Angioma (Progressive Capillary Hemangioma): A distinctive clinicopathologic entity related to lobular capillary hemangioma. Am J Dermpath 9:292-300, 1987 16. Ley RD, Padilla RS, Applegate LA: Ultraviolet radiation-induced blue nevi of the South American opossum, Monodelphis domestica. Photochem Photobiol (abstr) 45:78S, 1987 17. Eftekhari N, Padilla RS, Harville D: BCG granulomas in a dysplastic nevus syndrome. Int’l J Dermatol 27:36-37, 1988 18. Pennino R, Lowe B, Padilla RS, Gogel H: Contact tip probes used with the 1060 Nd:YAG laser. Lasers in Surg and Med (abstr) 8:143, 1988 19. Padilla RS, McConnell TS, Gribble JT: Malignant melanoma arising in a giant congenital melanocytic nevus: case report with cytogenetic and histopathologic analysis. Cancer 62:2589-2594, 1988 20. Padilla RS, Pennino RP: Carbon dioxide laser vaporization: relationship of scar formation to power density. J Dermatol Surg Onc (abstr) 15:232, 1989 21.
Burket JM, Zelickson AS, Padilla RS: Linear focal elastosis (elastotic striae) JAAD
20:633-636, 1989 22.
Dobry M, Padilla RS, Pennino R: Carbon dioxide laser vaporization: relationship of scar formation to power
density. J Investigative Dermatology 93:75-77, 1989 23.
Ley RD, Applegate LA, Padilla RS, Stuart TD: Ultraviolet radiation-induced malignant
melanoma in Monodelphis Domestica.
Photochem Photobio. 50:1-5, 1989 24.
Padilla RS, Shimazu C:
Malignant schwannoma treated by Mohs surgical excision. J Derm Surgery and Onc 17:793-796,
1991 25.
Whitehead RP, Friedman KD, Clark DA, Padilla RS: A phase I trial of subcutaneous interleukin
1. Proc of Am Assoc for Cancer Res (abstr)34:464, 1993 26.
Padilla RS, Snook RL:
Chest Nodule in a Middle Aged Woman J Derm Surgery and Onc, 1994;
21(3):204, March 1995 27.
Bigler C, Feldman J, Hall E, Padilla RS: Pigmented Basal Cell Carcinoma in
Hispanics. J Am Acad Dermatol. 1996; 34:751-2 28.
Gaughan MD, Padilla RS: Use of a Topical Fluorescent Dye to Evaluate Effectiveness of
Sunscreen Application. Arch Dermatol,
1998; 134:515-16 29.
Bang RH, Padilla RS:
Tufted Angioma. Letter to the
Editor in Int J of STD & AIDS
2000, June; 11:6:414 30.
Bordenave K, Griffith J, Hordes SM, Williams TM, Padilla RS: The Historical and Geomedical Immunogenetics
of Pemphigus Among the Decendants of Separdic Jews in New Mexico. Arch Dermatol, 2001; 137:825. 31.
Kalishman S, Padilla RS, Devoe P, Baca P: Using Lessons
from American Indian Health Professionals to a Health Science Center. Academic Medicine, May 2001; 76 (5):
500. 32.
Ortiz JK,
Gaughan MD, Bang RH, Padilla RS, Crooks LA.
A Case of Primary Mucinous Carcinoma of the Scalp Treated with Mohs
Surgery. Dermatologic Surgery, 2002; 28:751-754. 33.
Goodman WT,
Bang RH, Padilla RS:
Giant Dermatofibroma with Monster Cells. Am J Dermatopathol, 2002; 24:36-38. 34.
Prins C, Kerdel
FA, Padilla RS, Hunziker T: Treatment of Toxic Epidermal Necroloysis with High-Dose
Intravenous Immunoglobulin: multicentre retrospective analysis of 48
consecutive cases. Arch Dermatol, 2003;139:26-32. 35.
Tollestrup K,
Frost FJ, Cristiani M, McMillan GP, Calderon RL, Padilla RS. Arsenic-Induced Skin Conditions Identified
in Southwest Dermatology Practices: An
Epidemiologic Tool. Submitted for
publication. 36.
Prins C,
Vittorio C, Padilla RS, Hunziker T, Itin P, et al: Effect of High-Dose Intravenous
Immunoglobulin Therapy in Stevens-Johnson Syndrome. A Retrospective, Multicentre Study. Dermatology 2003;207(1):96-9. BOOK(S): Editor, Textbook of Dermatology Surgery, 1998 by Lippincott-Raven Publishers, 227 East Washington Square, Philadelphia, PA. BOOK CHAPTERS: 1.
Padilla RS: Acquired
“tufted” angioma, in Clinical Dermatology, DJ Demis et al.,
editors. Philadelphia, JB Lippincott
Co., 1989. Unit 7-66B, pp. 1-3. 2.
Padilla RS: Striae, in
Clinical Dermatology, DJ Demis et al., editors. Philadelphia, JB Lippincott Co., 1998. Unit 4-46, pp. 1-2. 3.
Padilla RS:
Hemangiopericytoma, in Clinical Dermatology, DJ Demis, et al.,
editors. Philadelphia, JB Lippincott
Co., 1990. Unit 7-70, pp. 1-3. 4.
Padilla RS: Glomus
Tumors, in Clinical Dermatology, DJ Demis et el., editors. Philadelphia, JB Lippincott Co., 1998. Unit 7-69, pp. 1-4. 5.
Padilla RS: Pyogenic
Granuloma (Granuloa Pyogenicum), in Clinical Dermatology, DJ Demis, et
al., editors. Philadelphia, JB
Lippincott Co., 1991, Unit 7-67, pp. 1-5. 6.
Padilla RS: Cancer of the Skin, in Conn’s Current Therapy
1993, RE Rakel, editor. WB Saunders
and Co., Sec 12, pp. 753-756. 7.
Padilla RS: Growth and
Development of Malignant Melanoma in Mohs Surgery, R. Bennett (ed.) Accepted
for publication. 8.
Padilla RS:
Dermabrasion in Cutaneous Surgery, RG Wheeland (ed.) WB Saunders
Co., Philadelphia, 1994. Ch. 38, pp.
479-490. 9.
Santos AD, Padilla RS:
Granuloma Annulare in Clinical Dermatology, DJ Demis et al.,
editors. Philadelphia, JB Lippincott
Co., 1994, Unit 4-7, pp. 1-7. 10.
Dunn PT, Padilla RS:
Necrobiosis Lipoidica Diabeticorum in Clinical Dermatology, DJ
Demis et al., editors. Philadelphia, JB
Lippincott Co., 1994, Unit 4-8, pp. 1-7. 11.
O’Sullivan RB, Padilla RS: Excision in Dermatologic Surgery, Chapter 13, pp.153-182, Philadelphia, JB
Lippincott Co., 1998. 12. Padilla RS, Yarborough JM: Dermabrasion in Dermatologic Surgery, Chapter 28, pp.473-484 . Philadelphia, JB Lippincott Co., 1998. 13. Richardson WR, Padilla RS: Dermatologic Disease in Native Americans in Textbook Dermatology and Dermatological Therapy of Pigmented Skins. Publication in progress. BOOK REVIEWS: 1.
Doing Right: Everyday Medical Ethics. (Solomon Papper, M.D.) JAAD 11:533,
1984. INFORMATIVE
ABSTRACTS: 1.
Effect of Route of Administration on the Selectivity of
Hematoporphyrin Derivative for Tumor Tissue.
E Elmer et al. J Derm Surgery
and Oncol 13:872, 1987. 2.
Photosensitization of Malignant Tumors. T Dougherty. J Derm Surgery and Oncol 13:897, 1987. 3.
Merkel Cell Carcinoma Report of a Case and Possible Role for
Adjuvant Radiotherapy. P Brown, et
al. J Derm Surgery and Oncol 13:897, 1987. 4.
Otolaryngologic Cases of Muchausen’s Syndrome. Y Zohar et al. J Dermatol Surg Oncol 13:978, 1987. 5.
Changes in Survival with Clinical Stage I Malignant
Melanoma. CP Karakousis et al. J Dermatol Surg Oncol 13:978, 1987. 6.
Zoned Immune Suppression of Lymph Nodes Draining Malignant
Melanoma – histologic and immunohistologic studies. AL Cohran et al. J Dermatol Surg Oncol 13:982, 1987. 7.
Nail Bed Melanoma, JM Klausner et al. J Dermatol Surg Oncol 13:985, 1987. 8.
Granulomatous Reactions in Mycosis Fungoides. K Dabski et al. J Dermatol Surg Oncol
13:982, 1987. 9.
First Bronchial Cleft Cysts – Clinical Update. D Finn et al. J Dermatol Surg Oncol
13:1024, 1987. 10.
Neodynium YAG Laser Photocoagulation of Hemangiomas of the
Head and Neck. S Shapshay et al. J Dermatol Surg Oncol 13:1024, 1987. 11.
Early Metastatic Patterns and Survival in Malignant
Melanoma. RN Nambison et al. J Dermatol Surg Oncol 13:1028, 1987. 12.
Etiological Differences Between Subtypes of Cutaneous
Malignant Melanoma. Western Canada
Melanoma Study. JM Elwood et al. J Dermatol Surg Oncol 13:1114, 1987. 13.
Leiomyosarcoma of the Scrotum. D St. J Collier. J
Dermatol Surg Oncol 13:1114, 1987. 14.
Histologic Characteristics of Vulvar Nevocellular Nevi. WN Christensen et al. J Dermatol Surg Oncol 13:1114, 1987. 15.
Carcinoma of the Nasal Vestibule Treated with Radiation
Therapy. NP Mendenhall et al. J Dermatol Surg Oncol 13:1114, 1987. 16.
Subungual Melanoma: A
25-Year Review of Cases. JM Daly. J Dermatol Surg Oncol 13:1108, 1987. 17.
Regression by Vitamin E of Experimental Oral Cancer. G Shklaw.
J Dermatol Surg Oncol 13:1094, 1987. 18.
Eccrine Sweat Gland Carcinoma: A Histologic and Immunohistochemical Study of 32 Cases. PE Swanson et al. J Dermatol Surg Oncol 13:1094, 1987. 19.
Effect of Surgical Treatment of Stage IV Melanoma. MA Hena.
J Dermatol Surg Oncol
13:1080, 1987. 20.
Malignancies of the External Ear Canal and Temporal Bone: Surgical Techniques and Results. SE Kinney et al. J Dermatol Surg Oncol
13:1186, 1987. 21.
Aggressive Digital Papillary Adenoma and Adenocarcinoma. A Clinico-pathologic Study of 57 Patients,
with Histochemical, Immunopathological
and Ultrastructural Observations. GF Kao et al. J
Dermatol Surg Oncol 13:1186, 1987. 22. Pancreatitis Associated with Isotretinoin-Induced Hypertrigyceridemia. WJ Flynn et
al. J Dermatol Surg Oncol 13:1234, 1987. 23.
Peanut Agglutinin Immunohistochemistry of Basal Cell
Carcinoma. N Vigneswaran et al. J Dermatol Surg Oncol 13:1261, 1987. 24. Elastic Fibers in Scar Tissue: Scannin and Transmission Electron Microscopic Studies. T Tsuji et al. J Dermatol Surg Oncol 13:1261, 1987. 25.
Incidence of Associated Diseases in Familial Polyposis
Coli. S. Bulow. J Dermatol Surg Oncol 13:1294, 1987. 26. Immediate Hypersensitivity Reactions to Beta-Lactam Antibiotics. A Saxon et al. J Dermatol Surg Oncol 13:1294, 1987. 27. Torre’s Syndrome in Association with Premalignant and Malignant Tumors and suspected Familial Polyposis. T Maipang et al. J Dermatol Surg Oncol 13:1310, 1987. 28.
Wound Healing in Sarcoma-Bearing Rats: Tumor Effects on Cutaneous and Deep
Wounds. WT Lawrence et al. J Dermatol Surg Oncol 13:1310, 1987. 29. Modulation of the Metastatic Phenotype by 13-cis-Retinoic Acid. MJ Couch et al. J Dermatol Surg Oncol 13:1325, 1987. 30. In Vivo Activation of Nude Mouse Macrophages by Human Melanoma Cells. A Benomar et al. J Dermatol Surg Oncol 13:1331, 1987. 31. Midline Destructive Granuloma: Fact or Fiction. D Harrison. J Dermatol Surg Oncol 14:40, 1988. 32. Low-Dose Danazol Therapy in Idiopathic Thrombocytopenic Purpura. Y Ahn et al. J Dermatol Surg Oncol 14:40, 1988 33.
Response to Radiotherapy of Head and Neck Tumors in AIDS
Patients. D Hommel et al. J Dermatol Surg Oncol 14:58, 1988. 34.
Natural History of Surgically Treated Mucosa Melanoma. J Wong et al. J Dermatol Surg Oncol
14:66, 1988. 35. Use of Permanent Hair Dyes and Risk of Breast Cancer. A Green et al. J Dermatol Surg Oncol 14:66, 1988.Nevus Sebaceous of Jadassohn: The 36.
Head and Neck Manifestations.
W Hagan. J Dermatol Surg
Oncol 14:66, 1988. 37.
Verrucous Pseudonevoid Melanoma. S Suster et al. J
Dermatol Surg Oncol 14:84, 1988. 38.
Pyoderma Gangrenosum of the Head and Neck, M Schwarz et
al. J Dermatol Surg Oncol 14:84, 1988. 39.
Squamous Cell Carcinoma of the Buccal Mucosa: Analysis of Prognostic Factors. M Hurist et al. J Dermatol Surg Oncol 14(2):122, 1988. 40.
Treatment of Advanced Squamous Cell Carcinoma of the Skin with
Isotretinoin. S Lippman et al. J Dermatol Surg Oncol 14(2):122,
1988. 41.
Adjuvant Chemotherapy in High-Risk Malignant Melanoma. C Karakousis et al. J Dermatol Surg Oncol 14(2):146,
1988. 42.
Seronegative Secondary Syphilis in a Patient Infected with the
Human Immunodeficiency Virus (HIV) with Kaposi Sarcoma. C Hicks et al. J Dermatol Surg Oncol
14(2):146, 1988. 43.
Infection with the Human Immunodeficiency Virus: Clinical Manifestations and Their
Relationship to Immune Deficiency. R
Kaslow et al. J Dermatol Surg Oncol 14(2):161, 1988. 44.
In Vivo Activation of Nude Mouse Macrophages by Human Melanoma
Cells. A Benomar et al. J Dermatol Surg Oncol 14(2):186, 1988. 45.
Cellular Blue Nevus Simulating Metastic Melanoma: Report of an Unusually Large Lesion
Associated with Nevus-Cell Aggregates in Regional Lymph Nodes. J
Sterchi et al. J Dermatol Surg Oncol 14(3):275, 1988. 46.
Antiibody to S-100 Protein Aids the Separation of Pagetoid
Melanoma
From Mammary and Extrammary
Paget’s Disease. BJ Glasgow et al. J Dermatol Surg Oncol 14(3):275,
1988. 47.
Air-Fluidized Beds or Conventional Therapy for Pressure
Sores. R. Allman et al. J Dermatol Surg Oncol 14(3):294,
1988. 48.
Superficial Epithelioma With Sebaceous Differentiation. K Friedman et al. J Dermatol Surg Oncol
14(3):294, 1988. 49.
Positive Relationship of Clinical and Surgical Responses to
Vaccinia Melanoma Oncolysate. MK
Wallack et al. J Dermatol Surg Oncol
14(4):391, 1988. 50. Mechanical Performance of Monofilament Synthetic Absorbable Sutures. GT Rodeheaver et al. J Dermatol Surg Oncol 14(4):391, 1988. 51.
Surgical Treatment of Lymph Nodes With Metastatic Melanoma
From Unknown Primary Sites. JH Wong et
al. J Dermatol Surg Oncol
14(4):38, 1988. 52.
Human T-Cells Specifically Activated Against Autologous
Malignant Melanoma. CL Slingluff et
al. J Dermatol Surg Oncol
14(4):438, 1988. 53.
Long-Term Survival in Malignant Melanoma With Special
Reference to Age and Sex as Prognostic Factors. M Thorn et al. J
Dermatol Surg Oncol 14(4):438,
1988. 54.
Prognosis for Recurrent Stage I Malignant Melanoma. DS Reintgen et al. J Dermatol Surg Oncol 14(4):452, 1988. 55.
Clear Cell Basal Cell Epithelioma: Light and Electron Microscopic Study at an Unusual Variant. MA Barnadas, RG Freeman. J Dermatol Surg Oncol 14(6):606,
1988. 56.
The Use of Topical Oral Antibiotics in Head and Neck
Prophylaxis: Is It Justified? JC Kirchner et al. J Dermatol Surg Oncol 14(6):606, 1988. 57.
Cutaneous Pathology Following Etoposide Therapy. BK Yokel et al. J Dermatol Surg Oncol 14(6):606, 1988. 58.
In Vitro Killing of Melanoma by Liposome-Delivered
Intracellular Irradiation. SS Pikull et
al. J Dermatol Surg Oncol
14(6):622, 1988. 59.
Carcinosarcoma of the Skin.
JA Tschen et al. J Dermatol
Surg Oncol 14(7):748, 1988. 60.
Juvenile Malignant Melanoma of the Head and Neck. DS Reintgen et al. J Dermatol Surg Oncol
14(6):686, 1988. 61.
Biostimulation of Human Carcinoma Cells with the Argon Laser:
A Previously Unreported Potential Iatrongenic Effect of Lasers. J Dermatol Surg Oncol 14(7):748,
1988. 62.
Suturing Techniques of Surgeons Utilizing Two Different
Needle-Holder Grips. S Seki. J Dermatol Surg Oncol 14(7):748,
1988. 63.
Narrowing Resection Margins for Patients with Low-Risk
Melanoma. L Goldman, R Byrd. J Dermatol Surg Oncol 14(7):748,
1988. 64.
Duration of Immunity After Hepatitis B Vaccination: Efficacy of Low-Dose
Booster Vaccine. M Horowitz et al. J Dermatol Surg Oncol 14(7):748, 1988. 65.
Natural History of Surgically Treated Mucosal Melanoma. JH Wong et al. J Dermatol Surg Oncol 14(7):804, 1988. 66.
An Unusual Skin Rash Associated with a Pancreatic
Polypeptide-Producing Tumor of the Pancreas.
UA Choksi et al. J Dermatol
Surg Oncol 14(7):804, 1988. 67.
Induction of HLA-DR Antigen on Human Squamous Carcinoma By
Recombinant Interferon Gamma. WM Koch
et al. J Dermatol Surg Oncol
14(8):825, 1988. 68.
Phototherapy With the Argon Laser on Human Melanoma Cells
“Sensitized” With Rhodamine-123: A New
Method for Tumor Growth Inhibition. DJ
Castro et al. J Dermatol Surg Oncol
14(8):825, 1988. 69.
Pharmacokinetics, Toxicity, and Short-term Results of
Cisplatin Hyperthermic Isolated Limb Perfusion for Soft-tissue Sarcoma and
Melanoma of the Extremities. RF Pommier
et al. J Dermatol Surg Oncol 14(8):825, 1988. 70.
Rhabdoid Skin Tumor:
An Uncommon Primary Skin Neoplasm.
Ultrastructural and Immunohistochemical Analysis. DJ Dabbs et al. J Dermatol Surg Oncol 14(8):870, 1988. 71.
Quantitation of S-100 Protein-positive Cells in Inflamed and
Noninflamed Keratoacanthoma and Squamous Cell Carcinoma. R Korenberg et al. J Dermatol Surg Oncol 14(8):870, 1988. 72.
Effect of Ultraviolet-B Radiation on the Vivo Growth of Murine
Melanoma Cells. CA Romerdahl et
al. J Dermatol Surg Oncol 15(1):104, 1989. 73.
Topical Vital Staining of Human Squamous Cell Carcinomas
Xenografts in Nude Mice. SA Estrem et
al. J Dermatol Surg Oncol
15(1):104, 1989. 74.
Immunoregulation of Caricogenesis: Past, Present and Future.
ML Kripke. J Dermatol Surg
Oncol 15(1):106, 1989. 75.
Non-Hodgkin Lymphoma of the Skin Excluding Mycosis Fungoides
and Cutaneous Involvement of Adult T-cell Leukemia/Lymphoma. K Mukai et al. J Dermatol Surg Oncol 15(1):107, 1989. 76.
Wound Prophylaxis With Metronidazole in Head and Neck Surgical
Oncology. RM Byers et al. J Dermatol Surg Oncol 15(1):107,
1989. 77.
Recognition of Malignant Melanoma by Monoclonal Antibody
HMB-45. An Immunohistochemical Study of
200 Paraffin-Embedded Cutaneous Tumors.
MR Wick et al. J Dermatol
Surg Oncol 15(1):107, 1989. 78.
The HIV tat Gene Induces Dermal Lesions Resembling Kaposi’s
Sarcoma in Transgenic Mice. J Vogel et
al. J Dermatol Surg Oncol
15:470, 1989. 79.
Dysplastic Nevi: A Histopathological
Investigation. AH Megregan J
Dermatol Surg Oncol 15:740, 1989. 80.
Reactive and Malignant “Angioedotheliomatosis”: A Discriminant
Clinicopathological Study. MR Wick et
al. J Dermatol Surg Oncol
15:571, 1989. 81.
Time and Frequency of Recurrence of Cutaneous Stage I
Malignant Melanoma with Guidelines for Follow-up Study. WH McCarthy et al. J Dermatol Surg Oncol 15:571, 1989. 82.
The Carcinogenic Risks of Modern Tanning Equipment: Is UV-A Safer Than UV-B? H van Weelden et al. J Dermatol Surg Oncol 15:574, 1989. 83.
The Place of Radiation Therapy in the Treatment of Squamous
Cell Carcinoma of Nasal Vestibule. CS
Wong et al. J Dermatol Surg Oncol
15:687, 1989. 84.
Characterization of Antigens Differentially Expressed by
Malignant Melanoma and Nevocellular Nevi.
JP Johnson et al. J Dermatol
Surg Oncol 15:779, 1989. 85.
Cultured, AIDS-Related Kaposi’s Sarcoma Cells Express
Endothelial Cell Markers and are Weakly Malignant in Vitro. WK Roth et al. J Dermatol Surg Oncol 15:781, 1989. 86.
Genetic Convergence and Divergence in Tumor Progression. S Heim et al. J Dermatol Surg Oncol 15:781, 1989. 87.
Identification of a Recurring Translocation Site Involving
Chromosome 6 in Human Malignant Melanoma.
M Trent et al. J Dermatol
Surg Oncol 15:889, 1989. 88.
The Risk of Otolaryngologists Who Treat Patients with AIDS and
AIDS Virus Infection: Report of an
In-Process Study. CD Sooy et al. J Dermatol Surg Oncol 15:891, 1989. 89. S-100 Protein: A Prognostic Indicator in Cutaneous Malignant Melanoma? NM Kernohan et al. J Dermatol Surg Oncol 15:892, 1989. 90.
Remission of Oral Leukoplakias and Micronuclei in
Tobacco/Betel Quid Chewers Treated with Beta-Carotene and with Beta-Carotene
Plus Vitamin A. HF Stich et al. J Dermatol Surg Oncol 15:1132, 1989. 91.
Expression of Neuroendocrine Cell Markers L-Dopa
Decarboxylase, Chromogranin A, and Dense Core Granules in Human Tumors of
Endocrine and Nonendocrive Origin Cancer.
AF Gazdar et al. J Dermatol
Surg Oncol 15:1133, 1989. 92.
Combined Modality Therapy for Tumor Stage Mycosis Fungoides: Results of a 10-Year Follow Up. DE Hallahan et al. J Dermatol Surg Oncol
15:1113, 1989. 93.
Analysis of Morpheaform Basal Cell Carcinoma: T Richman, NS Penneys. J Dermatol Surg Oncol 15:1304, 1989. 94.
Invited Review: What
Nevus is Dysplastic, a Syndrome and the Commonest Precursor of Malignant
Melanoma? A Riddle and an Answer. AB Ackerman. J Dermatol Surg Oncol
15:1304, 1989. 95. Incidence of Cutaneous Melanoma in the United States by Histology with Special Reference to the Face. GR Newell et al. J Dermatol Surg Oncol 15:1304, 1989. 96.
Detection and Identification of Activated Oncogenes in Human
Skin Cancers Occurring on Sun-Exposed Body Sites. HN Anathaswamy et al. J
Dermatol Surg Oncol 16:299, 1990. 97.
Primary Cutaneous Leiomyosarcoma: A Histological Immunohistochemical Study of 9 Cases, with
Ultrastructural Correlation. PE Swanson
et al. J Dermatol Surg Oncol 16:299, 1990. 98.
Immunohistochemical Demonstration of S-100 Protein and
Melanoma-Associated Antigens in Melanocytic Nevi. E Paul et al. J
Dermatol Surg Oncol 16:398, 1990. 99. Congenital
Augminated Spitz Nevi: Immunoreactivity
with a Melanoma-Associated Monoclonal Antibody. JP Palazzo, PH Duray. J
Dermatol Surg Oncol 13:698, 1990. 100. Cutaneous
Squamous Cell Carcinoma with Mucinous Metaplasia. KJ Friedman et al. J
Dermatol Surg Oncol 16:299, 1990. 101. Histopathologic
Staging at Initial Diagnosis of Mycosis Fungo8ides and the Sezary
Syndrome: Definition of Three
Distinctive Prognostic Groups. EA
Sausville et al. J Dermatol Surg
Oncol 16:492, 1990. 102. Cytogenetic
Analysis of Melanocytes from Pre-malignant Nevi and Melanomas. JM Cowan et al. J Dermatol Surg Oncol
16:493, 1990. 103. Comparison
of Absorbable Materials for Surgical Haical Hemostasis. SD Blair et al. J Dermatol Surg Oncol
16:493, 1990. |